Unveiling genetic insights: Array-CGH and WES discoveries in a cohort of 122 children with essential autism spectrum disorder

• Published in: BMC genomics 2024-12, Vol.25 (1), p.1186-17
• Main Authors: Granata, Paola, Zito, Alessandra, Cocciadiferro, Dario, Novelli, Antonio, Pessina, Chiara, Mazza, Tommaso, Ferri, Matteo, Piccinelli, Paolo, Luoni, Chiara, Termine, Cristiano, Fasano, Mauro, Casalone, Rosario
• Format: Article
• Language: English
• Subjects: Adolescent; Analysis; Anopheles; Array-comparative genomic hybridization (array-CGH); ASD; Autism; Autism Spectrum Disorder - genetics; Cardiac patients; Care and treatment; Child; Child, Preschool; Cohort Studies; Comparative analysis; Comparative Genomic Hybridization; Copy number variants (CNVs); Copy number variations; Diagnosis; DNA Copy Number Variations; DNA sequencing; Essential autistic spectrum disorder; Exome Sequencing; Female; Genes; Genetic aspects; Genetic Predisposition to Disease; Humans; Hybridization; Male; Methods; Nucleotide sequencing; Pervasive developmental disorders; Risk factors
• ISSN: 1471-2164; 1471-2164
• DOI: 10.1186/s12864-024-11077-5

Autistic Spectrum Disorder (ASD) is a neurodevelopmental disorder with a strong genetic component and high heterogeneity. Essential ASD refers to patients who do not have other comorbidities. This study aimed to investigate the genetic basis of essential ASD using whole exome sequencing (WES) and array-comparative genomic hybridization (array-CGH). In a cohort of 122 children with essential ASD, WES detected 382 variants across 223 genes, while array-CGH identified 46 copy number variants (CNVs). The combined use of WES and array-CGH revealed pathogenic variants in four patients (3.1% detection rate) and likely pathogenic variants in 34 patients (27.8% detection rate). Only one patient had a pathogenic CNV (0.8% detection rate). Including likely pathogenic variants, the overall detection rate was 31.2%. Additionally, 33 de novo heterozygous sequence variants were identified by WES, with three classified as pathogenic and 13 as likely pathogenic. Sequence variants were found in 85 genes already associated with ASD, and 138 genes not previously included in the SFARI dataset were identified as potential new candidate genes. The study enhances genetic understanding of essential ASD and identifies new candidate genes of interest. The findings suggest that using both array-CGH and WES in patients with essential ASD can improve the detection of pathogenic and likely pathogenic genetic variants, contributing to better diagnosis and potentially guiding future research and treatment strategies.